Proteomic analysis of human tears: defensin expression after ocular surface surgery

Journal of Proteome Research
L ZhouD Tan

Abstract

Human tear protein profiles were monitored by surface enhanced laser desorption/ionization-time-of-flight mass spectrometry ProteinChip technology (SELDI-TOF ProteinChip) and liquid chromatography-mass spectrometry (LC-MS). Tears were collected from 21 patients scheduled for surgery to remove an ocular surface neoplasm prior to surgery (day 0) and on days 1, 3, and 30 postoperatively. Using this proteomic approach, we verified that three human alpha-defensins (HNP-1, HNP-2, and HNP-3) were significantly up-regulated in their expression after surgery and that their levels decreased to approximately normal by day 30 by which time healing was complete. Further confirmation of the identity of the alpha-defensins in human tears was made by LC purification, trypsin digestion, and ESI-MS/MS analysis of their tryptic digests. The concentrations of HNP-1 and HNP-2 were determined and shown to be markedly increased after ocular surface surgery. The results of the study suggest that human alpha-defensins HNP-1, HNP-2, and HNP-3 are up-regulated after surgery, and may in addition to their antimicrobial properties have an important role in wound healing.

References

Feb 1, 1992·Current Opinion in Immunology·M Zasloff
Jun 1, 1990·Archives of Ophthalmology·J S CullorT W Reid
Oct 1, 1985·The Journal of Clinical Investigation·T GanzR I Lehrer
May 1, 1993·Journal of Cellular Physiology·C J MurphyT W Reid
May 16, 1998·The Journal of Clinical Investigation·E V ValoreT Ganz
Dec 29, 1998·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C ReitzJ Bours
Feb 27, 1999·Antimicrobial Agents and Chemotherapy·L O HattenbachS Kippenberger
May 26, 1999·The British Journal of Ophthalmology·R J HaynesH S Dua
Nov 5, 1999·Experimental Eye Research·N A McNAMARAS M Fleiszig
Jun 13, 2001·Current Eye Research·A M McDermottB Zhang
Aug 23, 2001·Journal of Immunological Methods·D L DiamondB A Dale
Nov 28, 2001·Proteomics·J D WulfkuhleE F Petricoin
Jan 16, 2002·Current Opinion in Immunology·Robert I Lehrer, Tomas Ganz
Apr 2, 2002·Biochemical and Biophysical Research Communications·Haleem J IssaqDonna Felschow
Feb 19, 2003·Rapid Communications in Mass Spectrometry : RCM·Lei ZhouDonald Tan

❮ Previous
Next ❯

Citations

May 18, 2011·Cellular and Molecular Life Sciences : CMLS·Satya S Kolar, Alison M McDermott
Aug 24, 2010·Cell and Tissue Research·Linda Hazlett, Minhao Wu
Jun 19, 2013·Experimental Eye Research·Roy KarnatiGordon W Laurie
Jul 25, 2013·Experimental Eye Research·Alison M McDermott
Dec 17, 2008·Analytical Chemistry·Michael S GardnerJames L Stephenson
Aug 5, 2008·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Gordon W LaurieJason J Nichols
Aug 29, 2007·Antimicrobial Agents and Chemotherapy·Ling C HuangAlison M McDermott
Feb 21, 2006·The British Journal of Ophthalmology·S Rodriguez-MartinezJ C Cancino-Diaz
May 5, 2012·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·David B AlexanderHiroyuki Tsuda
Jan 6, 2009·Ophthalmic Research·Alison M McDermott
Aug 8, 2013·BMC Ophthalmology·Zsolt TorokAdrienne Csutak
Jan 12, 2013·PloS One·Sivagnanam AnanthiKuppamuthu Dharmalingam
Oct 30, 2009·International Journal of Molecular Sciences·Lars SteinstraesserSammy Al-Benna
Jul 4, 2009·[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·Xing-ru ZhangAn-guo Sun
Jan 31, 2013·International Reviews of Immunology·Michael E SternStephen C Pflugfelder
May 29, 2012·Journal of Proteomics·Lei ZhouRoger W Beuerman
Jun 27, 2012·Progress in Retinal and Eye Research·Lei Zhou, Roger W Beuerman
Jul 31, 2007·The Ocular Surface·David J EvansSuzanne M J Fleiszig
Feb 4, 2012·Journal of Proteomics·Éva CsőszJózsef Tőzsér
Feb 3, 2009·Journal of Proteomics·Nathalie DroinEric Solary
Dec 4, 2008·Biotechnology Advances·John F Woolley, Mohamed Al-Rubeai
Jun 23, 2009·Biotechnology and Bioengineering·John F Woolley, Mohamed Al-Rubeai
May 1, 2008·Proteomics. Clinical Applications·Lorna M Cryan, Colm O'Brien
Aug 1, 2007·Proteomics. Clinical Applications·Franz H GrusNorbert Pfeiffer
Sep 1, 2007·Proteomics. Clinical Applications·Kaili Wu, Yanli Zhang
Sep 22, 2007·Biotechnology Journal·Chandra VermaRoger W Beuerman
Dec 25, 2008·Journal of Peptide Science : an Official Publication of the European Peptide Society·Shouping LiuRoger Beuerman
Mar 20, 2008·Chembiochem : a European Journal of Chemical Biology·Shouping LiuRoger W Beuerman
Oct 1, 2010·Electrophoresis·Aluru Venkata SaijyothiPadmanabhan Prema
Jun 12, 2013·Proteomics·Richard D SembaJennifer E Van Eyk
Mar 15, 2006·Experimental Eye Research·Kaijin WuSarah F Hamm-Alvarez
Nov 6, 2012·International Journal of Antimicrobial Agents·Nádia C SilvaManuela Pintado
Oct 25, 2011·American Journal of Ophthalmology·Stephen C Pflugfelder
Apr 7, 2010·Analytica Chimica Acta·Xiang ZhangCharles Buck
Oct 16, 2015·Rapid Communications in Mass Spectrometry : RCM·Gergő KallóÉva Csősz
Jul 30, 2005·FEMS Immunology and Medical Microbiology·G Sandra TjabringaPatrick L J M Zeeuwen
Nov 12, 2016·Biological Trace Element Research·Syed Rizwan AhamadFaiyaz Shakeel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.